Corindus Vascular Robotics (CVRS) Tops Q3 EPS by 1c

Corindus Vascular Robotics (NYSE: CVRS) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $3 million versus the consensus estimate of $3.16 million.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c